Score

Main information

  • Trade name:
  • Score cemented resurfacing patellar implant - Polyethylene patella prosthesis
  • Class:
  • Class III
  • Medicine domain:
  • Humans
  • Medicine type:
  • Medical device

Documents

Localization

  • Available in:
  • Score cemented resurfacing patellar implant - Polyethylene patella prosthesis
    Australia
  • Language:
  • English

Other information

Status

  • Source:
  • Dept. of Health,Therapeutic Goods Administration - Australia
  • Authorization number:
  • 216375
  • Last update:
  • 09-10-2017

Public Assessment Report

Public Summary

Summary for ARTG Entry:

216375

Amplitude Australia Pty Ltd - Score cemented resurfacing patellar implant - Polyethylene patella prosthesis

ARTG entry for

Medical Device Included Class III

Sponsor

Amplitude Australia Pty Ltd

Postal Address

Level 7/263 Clarence Street,SYDNEY, NSW, 2000

Australia

ARTG Start Date

23/10/2013

Product category

Medical Device Class III

Status

Active

Approval area

Medical Devices

Conditions

- The inclusion of the kind of device in the ARTG is subject to compliance with all conditions placed or imposed on the ARTG entry. Refer Part 4-5,

Division 2 (Conditions) of the Therapeutic Goods Act 1989 and Part 5, Division 5.2 (Conditions) of the Therapeutic Goods (Medical Devices) Regulations

2002 for relevant information.

- Breaching conditions of the inclusion related to the device of the kind may lead to suspension or cancellation of the ARTG entry; may be a criminal

offence; and civil penalties may apply.

Manufacturers

Name

Address

Amplitude

11 Cours Offenbach

Valence, , 26000

France

Products

1. Score cemented resurfacing patellar implant - Polyethylene patella prosthesis

Product Type

Single Device Product

Effective date

23/10/2013

GMDN

34199 Polyethylene patella prosthesis

Functional description

Component of Score total knee prosthesis. The resurfacing patellar implant is made of polyethylene, and is

to be affixed with bone cement.

Intended purpose

For use in a total knee prosthesis indicated for primary or secondary osteoarthritis, including revision of an

osteotomy; osteonecrosis; rheumatoid arthritis; post traumatic osteoarthritis; revising unicompartmental or

femoropatellar prostheses; revision arthroplasty.

Variant information

Diameter (mm) 30-39

Specific Conditions

No Specific Conditions included on Record

© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior

written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.

Public Summary

Page 1 of

Produced at 10.11.2017 at 05:12:45 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information

11-10-2018

Wild boar in focus: Review of existing models on spatial distribution and density of wild boar and proposal for next steps

Wild boar in focus: Review of existing models on spatial distribution and density of wild boar and proposal for next steps

Published on: Wed, 10 Oct 2018 00:00:00 +0200 This report provides a review of existing models for predicting the spatial distribution and abundance of wild boar at various scales (global, continental, national and regional) in order to inform the development of a new model to produce estimates of wild boar abundance at European level. The review identifies and discusses a range of models based on a wide variety of data types, corresponding to those targeted by the data collection model set by ENETwild,...

Europe - EFSA - European Food Safety Authority Publications

19-9-2018

Danish Medicines Agency aces European benchmark survey

Danish Medicines Agency aces European benchmark survey

The Danish Medicines Agency has just scored 4.5 of a possible 5 in the common-European survey known as the Benchmarking of European Medicines Agencies (BEMA). ”It's a really good result that will benefit all of us and may help raise the standard throughout Europe,” said the Danish health minister.

Danish Medicines Agency

There are no news related to this product.